FDA Approves Two Oral Antivirals against COVID-19 - India Got One of Them

COVID-19 Pandemic which started in 2019 is probably getting into its last phases as third wave hits India in December 2020-January 2021. Thankfully now we have got two oral drugs against SARS-CoV2 virus which is responible for COVID-19 diseases. So far as per our experience the latest variant of SARS-CoV2, aka Omnicron is the causative agent in the third wave.

America's drug controller FDA (Food and Drug Administration) has approved these two anti-COVID oral antivirals as Emergency Use Authorization (EUA) - Molnupiravir and Paxlovid. 

Buy Now Pay Later (BNPY) Offerings in India

Though 'buy now, pay later' schemes are available in the market in the form of credit cards in India for many years, new concept of BN-PY was around for 5-7 years. First I heard of LazyPay and Simpl from my brother who was using them in Chennai for heavily discounted foods and etc. Then I got to know about Ola Postpaid which offers cashless rides and generate a monthly or 15-day bill to pay the ride charges at one go. The best part of this BN-PY schemes are while you pay later there is no interest charge (similar to credit cards with 30 day bill) but often these are easy to grab (not subject to approval from banks for a credit cards) - so for students or youngsters LazyPay, Simpl, Ola Postpaid were a hit.